Fresenius Medical Care AG (FMS) Income from Non-Controlling Interests (2009 - 2026)

Fresenius Medical Care AG's Income from Non-Controlling Interests history runs 18 years deep, the most recent figure standing at $55.3 million for Q1 2026.

• In Q1 2026, Income from Non-Controlling Interests rose 36.95% year-over-year to $55.3 million; the TTM figure through Mar 2026 stood at $429.5 million (up 106.14% YoY), while the FY2025 annual figure was $247.9 million, up 14.3% from the prior year.
• Income from Non-Controlling Interests for Q1 2026 stood at $55.3 million, down from $259.6 million in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $259.6 million in Q4 2025, with the low at $40.4 million in Q1 2025.
• The 5-year median for Income from Non-Controlling Interests is $56.1 million (2022), against an average of $69.1 million.
• The sharpest annual moves came in 2022 and 2025: Income from Non-Controlling Interests plunged 33.71% in 2022, then surged 376.31% in 2025.
• Fresenius Medical Care AG's Income from Non-Controlling Interests stood at $56.1 million in 2022, then jumped by 32.3% to $74.2 million in 2023, then decreased by 26.59% to $54.5 million in 2024, then soared by 376.31% to $259.6 million in 2025, then sank by 78.7% to $55.3 million in 2026.
• Business Quant data shows FMS's Income from Non-Controlling Interests at $55.3 million in Q1 2026, $259.6 million in Q4 2025, and $61.4 million in Q3 2025.